Huperzine A is the main active ingredient of Huperzia Serrate,it is not only an efficient, highly selective reversible acetylcholinesterase inhibitor, but can improve learning and memory.In addition,it is regarded one of the special drugs to treat cerebral atrophy, brain (senile) dementia, osteoporosis and myasthenia gravis.For many years the active ingredient is widely concerned at home and abroad.
It was understood that the international market demand for Huperzia serrate in the United States and Italy reached more than 1,000 tons annual,the domestic demand was estimated at 500 tons.However,the annual output was less than 300 tons.The price also soared from 2011 with a rate of 67% owingt o the reduced output of Huperzia serrate.
Baoji Runyu told herbridge media,the high price of Huperzia serrate lead to the increased price of Huperzia Serrate extract.the order had gradually decreased with the effect of high price on the end-market demand.There was no doubt the emergence of alternatives may have an effect on the output of Huperzia serrate extract,
It is expected the future market of Huperzia serrate extract remains stable, but the price is unlikely to drop.
Copyright:Herbridge Media
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
